1 / 16

Innovative Pharmacy Services for Hyperlipidemia Management

Project ImPACT focuses on pharmacist-led services for hyperlipidemia management to improve patient outcomes and medication adherence. Pharmacists play a vital role in early detection, treatment, and patient education for cardiovascular health. The project aims to address the underdiagnosis and undertreatment of lipid disorders to enhance overall healthcare quality.

jaimeelliott
Télécharger la présentation

Innovative Pharmacy Services for Hyperlipidemia Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA

  2. The BIG Picture….

  3. Project ImPACT: Hyperlipidemia • National demonstration project of the APhA Foundation • Deployed in 29 Pharmacies across 14 states • Over 600 patients enrolled Sponsored through an unrestricted grant from Merck and Co.

  4. Project ImPACT: HyperlipidemiaRationale • Hyperlipidemia is a modifiable risk factor in coronary heart disease • Pharmacists services are widely accessible • Evidence suggest that pharmacists can improve both compliance and outcomes • A point-of-care testing device, the Cholestech LDX Analyzer is available to pharmacists with patient results available in 5 minutes • The management of cholesterol disorders represents a major benchmark by which health care quality can be evaluated

  5. Current Detection and Treatment • The majority of patients with lipid disorders are often not identified and not treated. • On average, only... • 35% of patients are diagnosed • 32% of patients are prescribed a diet • 12% of qualifying patients are prescribed a drug Adapted from Am J Cardiol 1998; 82:61-5

  6. Financial Burden of CADestimated in billions of dollars

  7. Patients Discontinuing Therapy n = 610 Simons, et al MJA 1996; 164:208

  8. Adherence Comparison Project ImPACT Model Existing Delivery System MJA 1996; 164:208, JAPhA 1998; 38:529-34.

  9. Medication Waste Costs for 1000 Patients in a Health Plan due to Noncompliance • MonthPts Discontinuing TxCost 1 200 x 1x $63 $12,600 2 50 x 2 x $63 $ 6,300 3 150 x 3 x $63 $28350 4 50 x 4 x $63 $12,600 5 50 x 5 x $63 $15,750 6 100 x 6 x $63 $37,800 7 50 x 7 x $63 $22,050 TOTAL COSTS $135,450

  10. Examples of Innovative Pharmacy Services • Osteoporosis • Cardiovascular Disease • Skin Damage • Weight Management • Glaucoma • Diabetes

  11. Examples of Innovative Pharmacy Services • Immunizations • Asthma • Smoking Cessation • Hypertension • Alzheimer’s • Depression • Urinary Incontinence

  12. How many have had these types of services provided by their pharmacist?

  13. The Pharmacist’s Role in Disease Prevention and Management • Perform patient risk assessment and health screening • Identify patients at risk • Support compliance and adherence to prescribed medication and behavioral therapies • Deliver patient education on disease prevention and disease management strategies

  14. The Pharmacist’s Role in Disease Prevention and Management • Refer to physician for follow-up • Physician provides diagnosis and prescribes therapy • Pharmacist monitors drug therapy • Provides ensures compliance and adherence • Immediate interventions when problems are identified

  15. Identifying Individuals at Risk • 80% of the population with osteoporosis is undiagnosed • 50% of the 2 million Americans with glaucoma are unaware that they have the disease • 33% of diabetics are unaware of their condition • 65% of patients with high cholesterol are unaware until their first cardiac event

  16. The Importance of Professional Collaboration • Less than 1% of physicians in the US are involved in preventive care programs • Time constraints • Financial incentives • Pharmacists become a referral source for physicians • Improved cooperation and information flow improves patient care

More Related